Continued |
Consolidated Financial Statements 2024 | ||||
Consolidated Financial Statements 2024 Continued |
in € million | Note | 2024 | 2023 |
Revenue | (5) | ||
Cost of sales | (5) | ( | ( |
Gross profit | |||
Selling and marketing expenses | ( | ( | |
General and administrative expenses | ( | ( | |
Restructuring | (6) | ( | ( |
Other income | (7) | ||
Other expenses | (8) | ( | ( |
EBIT | |||
Interest income | (11) | ||
Interest expenses on borrowings | ( | ( | |
Net income/(expense) on foreign exchange effects | (12) | ( | |
Other net financial expenses | (13) | ( | ( |
Net finance costs | ( | ( | |
Profit before income tax | |||
Income tax | (14) | ( | ( |
Profit after income tax | |||
RHI Magnesita N.V. shareholders | |||
Non-controlling interests | (26) | ||
in € | |||
Earnings per share - basic | (15) | ||
Earnings per share - diluted | (15) |
Consolidated Financial Statements 2024 | ||||
in € million | Note | 2024 | 2023 |
Profit after income tax | |||
Currency translation differences | |||
Unrealised results from currency translation | ( | ( | |
Deferred taxes thereon | (14) | ||
Reclassification to profit or loss | ( | ||
Cash flow hedges and costs of hedging | |||
Unrealised fair value changes | (35) | ( | |
Reclassification to profit or loss | ( | ( | |
Deferred taxes thereon | (14) | ( | |
Remeasurement of investments in debt instruments | |||
Unrealised fair value changes | ( | ||
Reclassification to profit or loss | |||
Items that may be reclassified to profit or loss in later periods | ( | ( | |
Remeasurement of defined benefit plans | |||
Remeasurement of defined benefit plans | (29) | ( | |
Deferred taxes thereon | (14) | ( | |
Items that are not reclassified to profit or loss in later periods | ( | ||
Other comprehensive (loss)/income after income tax | ( | ( | |
Total comprehensive income | |||
RHI Magnesita N.V. shareholders | |||
Non-controlling interests | (26) | ( |
Consolidated Financial Statements 2024 Continued |
in € million | Note | 31.12.2024 | 31.12.2023 |
ASSETS | |||
Non-current assets | |||
Goodwill | (17) | ||
Other intangible assets | (18) | ||
Property, plant and equipment | (19) | ||
Investments in joint ventures and associates | |||
Other financial assets | (34) | ||
Other assets | (20) | ||
Deferred tax assets | (14) | ||
Current assets | |||
Inventories | (21) | ||
Trade and other receivables | (22) | ||
Income tax receivables | (14) | ||
Other financial assets | (34) | ||
Cash and cash equivalents | (23) | ||
EQUITY AND LIABILITIES | |||
Equity | |||
Share capital | (24) | ||
Group reserves | (25) | ||
Equity attributable to shareholders of RHI Magnesita N.V. | |||
Non-controlling interests | (26) | ||
Non-current liabilities | |||
Borrowings | (27) | ||
Other financial liabilities | (28) | ||
Deferred tax liabilities | (14) | ||
Net employee defined benefit liabilities | (29) | ||
Provisions | (30) | ||
Other liabilities | |||
Current liabilities | |||
Borrowings | (27) | ||
Other financial liabilities | (28) | ||
Trade payables and other liabilities | (31) | ||
Income tax liabilities | (14) | ||
Provisions | (30) | ||
Consolidated Financial Statements 2024 | ||||
in € million | Note | 2024 | 2023 |
Cash generated from operations | (32) | ||
Income tax paid less refunds | ( | ( | |
Net cash flow from operating activities | |||
Investments in property, plant and equipment and intangible assets | ( | ( | |
Investments in subsidiaries net of cash acquired | ( | ( | |
Cash inflows from the sale of property, plant and equipment | |||
(Cash outflows) from investments in financial assets | ( | ( | |
Cash inflows from the sale of financial assets | |||
Dividends received from non-consolidated entities | |||
Investment subsidies received | |||
Prepayments related to the acquisition of Resco Group | ( | ||
Interest received | |||
Net cash used in investing activities | ( | ( | |
Payment for share issue costs in subsidiary | ( | ||
Proceeds from share issue in subsidiary | |||
Acquisition of non-controlling interests | ( | ( | |
Dividends paid to RHI Magnesita N.V. shareholders | ( | ( | |
Dividend paid to non-controlling interests | ( | ( | |
Proceeds from long-term financing | |||
Repayments of long-term financing | ( | ( | |
Changes in current borrowings and financial liabilities to associates | ( | ( | |
Interest payments | ( | ( | |
Repayment of lease obligations | ( | ( | |
Interest payments from lease obligations | ( | ( | |
Net cash (used in)/provided by financing activities | (33) | ( | |
Change in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of period | |||
Reclassification of Cash and Cash equivalents | (23) | ( | |
Foreign exchange impact | ( | ||
Cash and cash equivalents at end of period | (23) |
— 180 | |
Group reserves | |||||||||||
Accumulated other comprehensive income | |||||||||||
in € million | Share capital | Treasury shares | Additional paid-in capital | Mandatory reserve | Retained earnings | Cash flow hedges and costs of hedging | Defined benefit plans | Currency translation | Equity attributable to shareholders of RHI Magnesita N.V. | Non-controlling interests | Total equity |
Note | (24) | (25) | (25) | (25) | (25) | (25) | (25) | (25) | (26) | ||
31.12.2023 | ( | ( | ( | ||||||||
Profit after income tax | |||||||||||
Currency translation differences | ( | ( | ( | ||||||||
Cash flow hedges and costs of hedging | |||||||||||
Defined benefit plans | |||||||||||
Other comprehensive income after income tax | ( | ( | ( | ||||||||
Total comprehensive income | ( | ||||||||||
Dividends | ( | ( | ( | ( | |||||||
Share transfer/vested LTIP | ( | ||||||||||
Other changes1) | ( | ( | |||||||||
Share-based payment expenses | |||||||||||
Hedging gains and losses included in the initial cost of inventory purchased in the reporting period | ( | ( | ( | ||||||||
( | ( | ( | ( | ( | |||||||
31.12.2024 | ( | ( | ( | ||||||||
181 — | |
Group reserves | |||||||||||
Accumulated other comprehensive income | |||||||||||
in € million | Share capital | Treasury shares | Additional paid-in capital | Mandatory reserve | Retained earnings | Cash flow hedges | Defined benefit plans | Currency translation | Equity attributable to shareholders of RHI Magnesita N.V. | Non-controlling interests | Total equity |
Note | (24) | (25) | (25) | (25) | (25) | (25) | (25) | (25) | (26) | ||
31.12.2022 | ( | ( | ( | ||||||||
Profit after income tax | |||||||||||
Currency translation differences | ( | ( | ( | ( | |||||||
Cash flow hedges | ( | ( | ( | ||||||||
Defined benefit plans | ( | ( | ( | ||||||||
Other comprehensive income after income tax | ( | ( | ( | ( | ( | ( | |||||
Total comprehensive income | ( | ( | ( | ( | |||||||
Hedging gains and losses and costs of hedging transferred to the carrying value of inventory purchased during the year | |||||||||||
Dividends | ( | ( | ( | ( | |||||||
Share transfer/vested LTIP | ( | ||||||||||
Additions to consolidated companies and change of non-controlling interests without a change of control | |||||||||||
Change of non-controlling interests without a change of control | |||||||||||
Change of non-controlling interests without a change of control | ( | ||||||||||
Change of non-controlling interests without a change of control | ( | ( | ( | ( | |||||||
Hyperinflation adjustment | |||||||||||
Other changes1) | ( | ( | ( | ||||||||
Share-based payment expenses | |||||||||||
31.12.2023 | ( | ( | ( | ||||||||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Notes to the Consolidated Financial Statements 2024 | ||||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Notes to the Consolidated Financial Statements 2024 | ||||
Significant judgement: Control over Horn & Co Minerals Recovery At the end of the reporting period, the Group holds a 55.0% interest in Horn & Co Minerals Recovery (“Mireco”). The Group assessed its respective shareholding rights and power to control in terms of the purchase agreements, founding documents of Mireco and relevant corporate laws. Based on this assessment, the Group determined that it controls Mireco and consolidated it from the date of control. The Group exercises control over Mireco as it has the power to steer the relevant activities of the business and can use this power to affect the variable returns that it is exposed to. In determining that the Group controls Mireco, judgement is applied which takes into account the Group’s voting rights, management representation and the governance structure of Mireco. Control is achieved above all through the Group’s voting rights and the resulting influence on directing the relevant activities of the business. |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Customer relationships | 6 to 20 years |
Internally generated intangible assets | 4 to 18 years |
Other intangible assets | 4 to 65 years |
Real estate, land and buildings | 8 to 60 years |
Technical equipment and machinery | 8 to 50 years |
Other plant, office equipment, furniture and fixtures | 3 to 35 years |
Significant estimate: Useful lives of property, plant and equipment and intangible assets Management uses its experience to estimate the remaining useful life of an asset. The actual useful life of an asset may be impacted by an unexpected event that may result in an adjustment to the carrying amount of the asset. No such events are expected to arise which would have a material impact on carrying values within 12 months from the reporting date. |
Notes to the Consolidated Financial Statements 2024 | ||||
Significant estimate: Determination of recoverable amounts of CGUs which include goodwill Management makes use of various estimates and assumptions in determining the cash flow forecasts used to determine the recoverable amounts of CGUs to which goodwill is allocated for the annual impairment test. Key assumptions include discount rates used to discount cash flows, the perpetual annuity growth rate, projected revenue and projected EBIT margin of the associated CGU. For further details on impairment tests for CGUs which include goodwill, refer to Note (17). |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Significant judgement: Identification of impairment indicators related to individual assets and CGUs without goodwill Management reviewed individual assets and CGUs without goodwill for indicators of impairment. These indicators included both external factors affecting the recoverable amounts, such as laws and regulations in specific countries and global and local economic conditions and internal factors, including but not limited to, useful lives of assets, major breakdowns or decisions to divest from certain businesses or abandon investment projects. Based on the impairment indicator review, certain impairment indicators were identified in the reporting period that led to impairment losses at the level of individual assets totalling € 42 million. Refer to Notes (6), (8), (18) and (19) for details. |
Notes to the Consolidated Financial Statements 2024 | ||||
Significant judgement: Presentation of cash flows related to investments in and divestments of special national government bonds The Group maintains business operations in Argentina. In 2019, the Argentinian Central Bank imposed several foreign exchange restrictions on import payments, essentially preventing the Argentinian subsidiary’s ability to honour its payment obligations to suppliers outside of Argentina in the usual manner. Given a change in legislation in December 2023, Argentinian companies are now allowed to settle their previously restricted import payment obligations by purchasing U.S. dollar-denominated securities issued by the Central Bank of Argentina, also called BOPREAL bonds, which can be held to maturity, transferred or sold in the secondary market. In 2024 the Group has invested €19 million in these BOPREAL bonds all of which have been sold or transferred before the reporting date. The cash proceeds realised from the sales, amounting to €13 million, were used to settle intercompany and third-party trade liabilities. The cash flows arising from the investment in and divestment of the BOPREAL bonds are presented within the investing category in the Consolidated Statement of Cash Flows. Judgement is applied in determining that this presentation is appropriate, by taking into account the IFRS Accounting Standard requirements to classify cash flows and the fact that each of the above transactions is a separate unit of account. |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Significant Judgement: Own use exemption on gas and power forward purchase and physical delivery CO2-certificate forward contracts Due to the reduction of free CO2 emission certificates and the expected increase in CO2 market prices, the Group hedges the associated price risk by use of physical delivery forward purchases for own use. The Group also enters into fixed price and quantity forward gas and power contracts to secure supply for its production process and reduce price volatility. The own use exemption does not require fair value recognition and measurement of the forward purchases and thus volatility in the Consolidated Statement of Profit or Loss can be avoided. The own use exemption requires contracts to be entered into and continued to be held for delivery and usage requirements of the Group. The Group settles most of these forward contracts through physical delivery and does not expect to sell any (unexpected) surplus quantities of either gas, power or CO2 emission certificates. Management have judged that these forward purchases based on current and expected future requirements satisfy the own use exemption and have not applied fair value recognition and measurement. However, if surplus quantities of either gas, electricity or CO2 emission certificates are expected to be sold, the corresponding forward contracts are accounted for as derivative financial instruments whose changes in fair value are recognised in the Consolidated Statement of Profit and Loss. |
Notes to the Consolidated Financial Statements 2024 | ||||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Significant estimate: Measurement of other provisions The recognition and measurement of other provisions disclosed in Note (30) are based on best estimates using the information available at the reporting date. The estimates take into account the underlying legal or constructive obligation and are performed by internal experts or, when appropriate, also by external experts. Despite the best possible assumptions and estimates, cash outflows expected at the reporting date may deviate from actual cash outflows. As soon as additional information is available, the estimates made are reviewed and provisions are also adjusted. The majority of other provisions refers to an unfavourable contract which was recognised in the course of acquiring the former Magnesita Group and is mainly based on an estimate of foregone profit margins compared to market conditions. Moreover, restructuring provisions and provisions related to the rehabilitation and restoration of the mining sites or for environmental damages are recorded within other provisions. These are subject to measurement uncertainties in terms of the estimated costs to settle the obligation, estimated term until rehabilitation and restoration, discount rate and inflation rate. Changes in these parameters may result in higher or lower provisions. |
Notes to the Consolidated Financial Statements 2024 | ||||
Significant estimate: Pension plans and other post-employment benefits classified as defined benefit plans The measurement of defined benefit obligation and plan assets requires use of estimates such as discount rates, mortality rates, salary increases and inflation. These estimates are reviewed and updated when a valuation is performed by third-party experts. Further details of the estimates and assumptions together with sensitivities on changes to assumptions is reflected in Note (29). Changes in these assumptions may result in differences between cash outflows expected at the reporting date and actual cash outflows. |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Significant judgement: Uncertain tax treatments and recognition of deferred tax assets Management makes judgements in relation to the recognition of current and deferred income taxes. In making judgements, management believes that the tax positions the Group adopts are in line with the applicable legislation and reflect the probable outcome. The tax obligations and receivables, upon audit by the tax authorities at a future date, may differ as a result of differing interpretations. These interpretations may impact the expected timing and quantum of taxes payable and recoverable. |
Significant estimates: Recognition of deferred tax assets Income tax expense is based on the tax laws applicable in the individual countries. Due to their complexity, the tax items presented may be subject to different interpretations by local tax authorities. When determining the amount of the deferred tax assets to be recognised, mainly relating to tax losses, an estimate is required of future taxable income which is influenced by factors such as prices, gross profit margins and interest rates. A 10% change in the future taxable profit from the assumption made on the reporting date within the planning period defined for the accounting and measurement of deferred taxes would not result in a significant change in the carrying amount of deferred tax assets on recognised tax losses, over a 12-month period from the date of these Consolidated Financial Statements. Refer to Note (14) for details on recognised deferred tax assets. |
Notes to the Consolidated Financial Statements 2024 | ||||
Significant Judgement: Revenue recognition For specific customer contracts in the reportable segment Steel with variable payment arrangements where the transaction price depends on the customer’s production output, (e.g. quantity of steel produced) management has determined that the commitment to transfer each of the products and services to the customer is not separately identifiable from the other commitments in the context of such contracts. The customer expects complete refractory management for the agreed product areas in the steel plant in order to enable steel production. Thus, only one performance obligation, being the performance of a management refractory service, exists. Revenue from the delivery of management refractory services is recognised over time and, by applying the practical expedient, corresponds to the amounts that the Group is entitled to invoice to the customer on a regular basis according to the contract terms. |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
31.12.2024 | 31.12.2023 | |
Price level | 7,694.01 | 3,533.19 |
Index movement (in %) | 118 | 211 |
Notes to the Consolidated Financial Statements 2024 | ||||
Closing rate | Average rate1) | ||||
Currencies | 1 € = | 31.12.2024 | 31.12.2023 | 2024 | 2023 |
Brazilian Real | BRL | 6.46 | 5.37 | 5.79 | 5.42 |
Canadian Dollar | CAD | 1.50 | 1.46 | 1.48 | 1.46 |
Chinese Renminbi Yuan | CNY | 7.61 | 7.87 | 7.79 | 7.65 |
Indian Rupee | INR | 89.11 | 92.58 | 90.68 | 89.20 |
US Dollar | USD | 1.04 | 1.11 | 1.09 | 1.08 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Notes to the Consolidated Financial Statements 2024 | ||||
Steel | Industrial | Minerals | ||||
2024 in € million | Cement & Lime | Non-Ferrous Metals | Process Industries | Group 2024 | ||
Revenue | 2,373 | 376 | 247 | 426 | 65 | 3,487 |
Gross profit | 551 | 83 | 110 | 101 | 3 | 848 |
EBIT | 242 | |||||
Net finance costs | (42) | |||||
Profit before income tax | 200 | |||||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Steel | Industrial | Minerals | ||||
2023 in € million | Cement & Lime | Non-Ferrous Metals | Process Industries | Group 2023 | ||
Revenue | 2,461 | 424 | 281 | 326 | 80 | 3,572 |
Gross profit | 550 | 105 | 119 | 74 | 9 | 857 |
EBIT | 333 | |||||
Net finance costs | (100) | |||||
Profit before income tax | 233 | |||||
Steel | Industrial | Minerals | ||||
in € million | Cement & Lime | Non-Ferrous Metals | Process Industries | Group 2024 | ||
Shaped refractory products | 1,097 | 311 | 204 | 314 | 0 | 1,926 |
Unshaped refractory products | 579 | 51 | 21 | 57 | 0 | 708 |
Flow control refractory products | 553 | 0 | 0 | 0 | 0 | 553 |
Other refractory products | 27 | 5 | 3 | 18 | 0 | 53 |
Systems, sensors, machinery and digital products | 19 | 3 | 8 | 5 | 0 | 35 |
Services | 88 | 6 | 9 | 32 | 0 | 135 |
Raw materials | 10 | 0 | 2 | 0 | 65 | 77 |
Revenue | 2,373 | 376 | 247 | 426 | 65 | 3,487 |
Steel | Industrial | Minerals | ||||
in € million | Cement & Lime | Non-Ferrous Metals | Process Industries | Group 2023 | ||
Shaped refractory products | 1,177 | 340 | 231 | 233 | 0 | 1,981 |
Unshaped refractory products | 591 | 63 | 32 | 45 | 0 | 731 |
Flow control refractory products | 555 | 0 | 0 | 0 | 0 | 555 |
Other refractory products | 32 | 6 | 3 | 15 | 0 | 56 |
Systems, sensors, machinery and digital products | 21 | 4 | 7 | 3 | 0 | 35 |
Services | 71 | 10 | 6 | 30 | 0 | 117 |
Raw materials | 14 | 1 | 2 | 0 | 80 | 97 |
Revenue | 2,461 | 424 | 281 | 326 | 80 | 3,572 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Netherlands | 15 | 14 |
USA | 584 | 612 |
India | 445 | 477 |
Brazil | 353 | 371 |
China | 260 | 260 |
Other countries | 1,830 | 1,838 |
Revenue | 3,487 | 3,572 |
in € million | 31.12.2024 | 31.12.2023 |
Brazil | 407 | 503 |
India | 392 | 383 |
Austria | 343 | 368 |
USA | 235 | 225 |
Germany | 205 | 212 |
China | 188 | 201 |
Other countries | 274 | 277 |
Goodwill, intangible assets and property, plant and equipment | 2,044 | 2,169 |
in € million | 2024 | 2023 |
Restructuring (expenses) | (32) | (20) |
Restructuring income | 8 | 0 |
Restructuring (expenses) - net | (24) | (20) |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Net amortisation of Oberhausen provision | 14 | 11 |
Gains from the disposal of non-current assets | 6 | 3 |
Bargain purchase gain | 0 | 8 |
Miscellaneous income | 18 | 5 |
Other income | 38 | 27 |
in € million | 2024 | 2023 |
Expenses for strategic projects | (75) | (16) |
Impairment of property, plant and equipment and intangible assets | (37) | 0 |
Losses from the disposal of non-current assets | (3) | (7) |
Miscellaneous expenses | (24) | (16) |
Other expenses | (139) | (39) |
in € million | 2024 | 2023 |
Cost of materials | (1,352) | (1,375) |
Personnel costs | (806) | (747) |
Energy costs | (225) | (257) |
Freight expenses | (201) | (229) |
Depreciation and amortisation charges | (175) | (178) |
External services | (173) | (164) |
Changes in inventories, own work capitalised | (11) | (54) |
Write-down expenses | (42) | (1) |
Other income and expenses | (260) | (234) |
Total expenses | (3,245) | (3,239) |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Wages and salaries | (634) | (579) |
Social security contribution | (121) | (113) |
Fringe benefits | (32) | (33) |
Pension and other post-employment benefits | ||
Defined contribution plans | (12) | (11) |
Defined benefit plans | (4) | (4) |
Other expenses termination benefits | (3) | (7) |
Personnel expenses (without interest expenses) | (806) | (747) |
2024 | 2023 | |
Salaried employees | 7,426 | 7,063 |
Waged workers | 8,626 | 7,953 |
Number of employees on annual average | 16,052 | 15,016 |
in € million | 2024 | 2023 |
Foreign exchange gains/(losses) | 30 | (44) |
(Losses)/gains on forward exchange contracts and derivatives in open orders | (18) | 11 |
(Loss)/gain on net monetary position | (1) | 3 |
Net income/(expense) on foreign exchange effects | 11 | (30) |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Net interest expense relating to personnel provisions | (12) | (12) |
Unwinding of discount of provisions and payables | (7) | (8) |
Interest income/(expense) on non-controlling interest liabilities | 1 | (7) |
Interest expense on lease liabilities | (3) | (2) |
Income from the revaluation of NCI put options | 21 | 7 |
Other interest and similar income and expenses1) | (14) | (10) |
Other net financial expenses | (14) | (32) |
in € million | 2024 | 2023 |
Current tax expense | (51) | (67) |
Deferred tax (expense)/income relating to | ||
temporary differences | (4) | 9 |
tax loss carryforwards | 9 | (4) |
5 | 5 | |
Income tax | (46) | (62) |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Profit before income tax | 200 | 233 |
Income tax expense calculated at 23% (2023: 24%) | 46 | 56 |
Different foreign tax rates | 8 | 2 |
Expenses not deductible and additions to tax base, non-creditable taxes | 22 | 28 |
Non-taxable income and tax benefits | (30) | (28) |
Tax losses and temporary differences of the financial year not recognised | 5 | 1 |
Utilisation of previously unrecognised loss carryforwards and temporary differences | (5) | (1) |
Deferred tax expense due to tax rate changes | 1 | 2 |
Deferred income tax relating to previous periods | 4 | (7) |
Income tax relating to foreign currency translation of local currency to functional currency | 0 | 4 |
Current income tax relating to prior periods | (5) | 5 |
Recognised tax expense | 46 | 62 |
Effective tax rate (in %) | 23.0% | 26.7% |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
31.12.2024 | 2024 | 31.12.2023 | 2023 | |||
in € million | Deferred tax assets | Deferred tax liabilities | (Expense)/Income | Deferred tax assets | Deferred tax liabilities | (Expense)/Income |
Property, plant and equipment, intangible assets | 28 | 107 | 8 | 29 | 121 | 3 |
Inventories | 26 | 10 | 4 | 24 | 10 | 0 |
Trade receivables, other assets | 14 | 22 | (10) | 12 | 9 | 12 |
Pensions and other personnel provisions | 35 | 0 | (1) | 45 | 0 | (5) |
Other provisions | 23 | 0 | (2) | 30 | 0 | 2 |
Trade payables, other liabilities | 39 | 5 | (3) | 28 | 6 | (3) |
Tax loss carried forward | 67 | 0 | 9 | 67 | 0 | (4) |
Offsetting | (80) | (80) | 0 | (83) | (83) | 0 |
Deferred taxes | 152 | 64 | 5 | 152 | 63 | 5 |
in € million | 31.12.2024 | 31.12.2023 |
Country | ||
Brazil | 51 | 61 |
Luxembourg | 0 | 61 |
China | 37 | 24 |
UK | 6 | 18 |
Dubai | 4 | 4 |
Germany | 6 | 6 |
France | 5 | 4 |
Others | 3 | 3 |
Total | 112 | 181 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 31.12.2024 | 31.12.2023 |
Year of expiry | ||
2024 | 0 | 6 |
2025 | 1 | 2 |
2026 | 2 | 2 |
2027 | 10 | 8 |
2028 | 6 | 6 |
2029 | 19 | 0 |
2030 or later | 0 | 1 |
Not subject to expiration | 74 | 156 |
Total unrecognised tax losses | 112 | 181 |
2024 | 2023 | |
Profit after income tax attributable to RHI Magnesita N.V. shareholders (in € million) | 142 | 165 |
Weighted average number of shares for basic EPS | 47,170,570 | 47,078,254 |
Effects of dilution from share options | 1,154,648 | 1,014,964 |
Weighted average number of shares for dilutive EPS | 48,325,218 | 48,093,218 |
Earnings per share basic (in €) | 3.01 | 3.50 |
Earnings per share diluted (in €) | 2.94 | 3.42 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Carrying amount at beginning of year | 339 | 137 |
Business combinations and PPA finalisation | 3 | 197 |
Currency translation | (3) | (2) |
Hyperinflation adjustment | 3 | 7 |
Carrying amount at year-end | 342 | 339 |
Notes to the Consolidated Financial Statements 2024 | ||||
2024 | 2023 | |||||
Discount rate before Tax | Perpetual annuity growth rate | Goodwill in € million | Discount rate before Tax | Perpetual annuity growth rate | Goodwill in € million | |
Steel - Linings | 9.7% | 0.9% | 218 | 9.9% | 0.9% | 213 |
Steel - Flow Control | 10.3% | 0.9% | 67 | 10.0% | 0.9% | 67 |
Industrial - Cement & Lime | 10.7% | 0.9% | 56 | 10.5% | 0.9% | 55 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | Mining rights | Customer relationship | Internally generated intangible assets | Other intangible assets | Prepayments made and intangible assets under construction | Total |
Cost at 31.12.2023 | 152 | 284 | 87 | 170 | 22 | 715 |
Currency translation | (10) | 3 | (1) | 0 | 0 | (8) |
Additions | 0 | 0 | 5 | 1 | 0 | 6 |
Initial consolidation and PPA finalisation | 0 | (2) | 0 | 0 | 0 | (2) |
Retirements and disposals | 0 | 0 | (1) | (16) | 0 | (17) |
Reclassifications | 3 | 0 | 0 | 3 | (6) | 0 |
Cost at 31.12.2024 | 145 | 285 | 90 | 158 | 16 | 694 |
Accumulated amortisation 31.12.2023 | 17 | 64 | 53 | 111 | 0 | 245 |
Currency translation | (1) | 0 | 0 | (1) | 0 | (2) |
Amortisation charges | 2 | 20 | 3 | 14 | 0 | 39 |
Impairment charges | 0 | 0 | 7 | 0 | 0 | 7 |
Retirements and disposals | 0 | 0 | 0 | (12) | 0 | (12) |
Accumulated amortisation 31.12.2024 | 18 | 84 | 63 | 112 | 0 | 277 |
Carrying amounts at 31.12.2024 | 127 | 201 | 27 | 46 | 16 | 417 |
in € million | Mining rights | Customer relationship | Internally generated intangible assets | Other intangible assets | Prepayments made and intangible assets under construction | Total |
Cost at 31.12.2022 | 152 | 132 | 79 | 157 | 0 | 520 |
Currency translation | 1 | (5) | 0 | (2) | 0 | (6) |
Additions | 0 | 0 | 8 | 2 | 0 | 10 |
Additions initial consolidation | 0 | 159 | 0 | 6 | 8 | 173 |
Retirements and disposals | (1) | 0 | 0 | (1) | 0 | (2) |
Reclassifications | 0 | (2) | 0 | 8 | 14 | 20 |
Cost at 31.12.2023 | 152 | 284 | 87 | 170 | 22 | 715 |
Accumulated amortisation 31.12.2022 | 15 | 45 | 49 | 94 | 0 | 203 |
Currency translation | (1) | (1) | 0 | 1 | 0 | (1) |
Amortisation charges | 3 | 20 | 4 | 17 | 0 | 44 |
Reclassifications | 0 | 0 | 0 | (1) | 0 | (1) |
Accumulated amortisation 31.12.2023 | 17 | 64 | 53 | 111 | 0 | 245 |
Carrying amounts at 31.12.2023 | 135 | 220 | 34 | 59 | 22 | 470 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Remaining useful life in years | 31.12.2024 Net book value | 31.12.2023 Net book value |
Mining rights | |||
Brazil | 49 | 63 | 77 |
US | 46 | 61 | 58 |
Customer relationships | |||
RHI Magnesita India Refractories Ltd and RHI Magnesita Seven Refractories Ltd | 8-18 | 91 | 95 |
Former Magnesita Group | 4-8 | 48 | 55 |
Seven Refractories Group | 14 | 21 | 26 |
RHI Magnesita India / Hi-Tech Chemicals Ltd | 4 | 21 | 22 |
Land use rights | 13-53 | 20 | 24 |
in € million | Real estate, land and buildings | Technical equipment, machinery | Other plant, furniture and fixtures | Prepayments made and plant under construction | Right-of-use assets | Total |
Cost at 31.12.2023 | 758 | 1,231 | 417 | 267 | 134 | 2,807 |
Currency translation | (13) | (10) | (9) | (25) | (3) | (60) |
Additions1) | 6 | 49 | 9 | 68 | 29 | 161 |
Initial consolidation and PPA finalisation | 5 | (2) | 0 | (1) | 0 | 2 |
Retirements and disposals | (31) | (97) | (42) | (6) | (13) | (189) |
Reclassifications | 26 | 106 | 32 | (167) | 0 | (3) |
Cost at 31.12.2024 | 751 | 1,277 | 407 | 136 | 147 | 2,718 |
Accumulated depreciation 31.12.2023 | 304 | 814 | 271 | 1 | 57 | 1,447 |
Currency translation | (1) | (2) | (3) | (1) | (3) | (10) |
Depreciation charges | 21 | 61 | 32 | 0 | 22 | 136 |
Impairment charges | 0 | 9 | 0 | 26 | 0 | 35 |
Retirements and disposals | (29) | (93) | (41) | 0 | (12) | (175) |
Accumulated depreciation 31.12.2024 | 295 | 789 | 259 | 26 | 64 | 1,433 |
Carrying amounts at 31.12.2024 | 456 | 488 | 148 | 110 | 83 | 1,285 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | Real estate, land and buildings | Technical equipment, machinery | Other plant, furniture and fixtures | Prepayments made and plant under construction | Right-of-use assets | Total |
Cost at 31.12.2022 | 712 | 1,143 | 393 | 232 | 112 | 2,592 |
Currency translation | (1) | (2) | 1 | 3 | 0 | 1 |
Additions1) | 14 | 19 | 11 | 127 | 14 | 185 |
Additions initial consolidation | 52 | 51 | 6 | 6 | 22 | 137 |
Retirements and disposals | (35) | (24) | (15) | 0 | (14) | (88) |
Reclassifications | 16 | 44 | 21 | (101) | 0 | (20) |
Cost at 31.12.2023 | 758 | 1,231 | 417 | 267 | 134 | 2,807 |
Accumulated depreciation 31.12.2022 | 317 | 768 | 252 | 1 | 50 | 1,388 |
Currency translation | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation charges | 17 | 67 | 30 | 0 | 20 | 134 |
Impairment charges | 0 | 0 | 1 | 0 | 0 | 1 |
Retirements and disposals | (30) | (21) | (13) | 0 | (14) | (78) |
Reclassifications | 0 | 0 | 1 | 0 | 0 | 1 |
Accumulated depreciation 31.12.2023 | 304 | 814 | 271 | 1 | 57 | 1,447 |
Carrying amounts at 31.12.2023 | 454 | 417 | 146 | 266 | 77 | 1,360 |
in € million | Right-of-use assets land and buildings | Right-of-use assets technical equipment and machinery | Right-of-use assets other equipment, furniture and fixtures | Total |
Cost at 31.12.2023 | 91 | 30 | 13 | 134 |
Currency translation | (1) | (2) | 0 | (3) |
Additions | 17 | 3 | 9 | 29 |
Retirements and disposals | (5) | (5) | (3) | (13) |
Cost at 31.12.2024 | 102 | 26 | 19 | 147 |
Accumulated depreciation 31.12.2023 | 30 | 20 | 7 | 57 |
Currency translation | 0 | (2) | (1) | (3) |
Depreciation charges | 12 | 5 | 5 | 22 |
Retirements and disposals | (5) | (5) | (2) | (12) |
Accumulated depreciation 31.12.2024 | 37 | 18 | 9 | 64 |
Carrying amounts at 31.12.2024 | 65 | 8 | 10 | 83 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Right-of-use assets land and buildings | Right-of-use assets technical equipment and machinery | Right-of-use assets other equipment, furniture and fixtures | Total |
Cost at 31.12.2022 | 69 | 33 | 10 | 112 |
Additions | 9 | 1 | 4 | 14 |
Additions initial consolidation | 21 | 1 | 0 | 22 |
Retirements and disposals | (8) | (5) | (1) | (14) |
Cost at 31.12.2023 | 91 | 30 | 13 | 134 |
Accumulated depreciation 31.12.2022 | 25 | 19 | 6 | 50 |
Currency translation | 0 | 1 | 0 | 1 |
Depreciation charges | 12 | 5 | 3 | 20 |
Retirements and disposals | (7) | (5) | (2) | (14) |
Accumulated depreciation 31.12.2023 | 30 | 20 | 7 | 57 |
Carrying amounts at 31.12.2023 | 61 | 10 | 6 | 77 |
in € million | 31.12.2024 | 31.12.2023 |
Prepayments related to the acquisition of Resco Group | 46 | 0 |
Deferred mine stripping costs | 13 | 12 |
Tax receivables | 11 | 14 |
Other non-current assets | 6 | 11 |
Other non-current assets | 76 | 37 |
in € million | 31.12.2024 | 31.12.2023 |
Raw materials and supplies | 264 | 274 |
Work in progress | 215 | 220 |
Finished products and goods | 464 | 489 |
Prepayments made | 14 | 13 |
Emission rights1) | 5 | 5 |
Inventories | 962 | 1,001 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 31.12.2024 | 31.12.2023 |
Trade receivables | 530 | 538 |
Contract assets | 3 | 4 |
Other tax receivables | 87 | 95 |
Prepaid expenses | 9 | 8 |
Other current receivables1) | 31 | 36 |
Trade and other current receivables | 660 | 681 |
thereof financial assets | 533 | 542 |
thereof non-financial assets | 127 | 139 |
in € million | 31.12.2024 | 31.12.2023 |
Cash at banks and in hand | 530 | 644 |
Money market funds | 46 | 60 |
Cash and cash equivalents | 576 | 704 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 31.12.2024 | 31.12.2023 |
Non-current assets | 432 | 420 |
Current assets | 260 | 258 |
Non-current liabilities | (24) | (18) |
Current liabilities | (123) | (152) |
Net assets before intragroup eliminations | 545 | 508 |
Intragroup eliminations | (1) | (2) |
Net assets | 544 | 506 |
Carrying amount of non-controlling interests | 162 | 149 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Revenue | 430 | 427 |
Operating expenses, net finance costs and income tax | (406) | (410) |
Profit after income tax before intragroup eliminations | 24 | 17 |
Intragroup eliminations | 1 | (2) |
Profit after income tax | 25 | 15 |
thereof attributable to non-controlling interests | 11 | 6 |
in € million | 2024 | 2023 |
Profit after income tax | 24 | 15 |
Other comprehensive income/(expense) | 26 | (33) |
Total comprehensive income | 50 | (18) |
thereof attributable to non-controlling interests | 22 | (8) |
in € million | 2024 | 2023 |
Net cash flow from operating activities | 38 | 38 |
Net cash flow from investing activities | (13) | (123) |
Net cash flow from financing activities | (26) | 75 |
Total cash flow | (1) | (10) |
Notes to the Consolidated Financial Statements 2024 | ||||
Total | |||
in € million | 31.12.2024 | Current | Non-current |
Syndicated & Term Loan | 976 | 233 | 743 |
Bonded loans ("Schuldscheindarlehen") | 720 | 0 | 720 |
Other credit lines and other loans | 44 | 42 | 2 |
Total liabilities to financial institutions | 1,740 | 275 | 1,465 |
Other financial liabilities | 11 | 1 | 10 |
Capitalised transaction costs | (1) | 0 | (1) |
Borrowings | 1,750 | 276 | 1,474 |
Total | |||
in € million | 31.12.2023 | Current | Non-current |
Syndicated & Term Loan | 1,114 | 45 | 1,069 |
Bonded loans ("Schuldscheindarlehen") | 755 | 35 | 720 |
Other credit lines and other loans | 63 | 60 | 3 |
Total liabilities to financial institutions | 1,932 | 140 | 1,792 |
Other financial liabilities | 18 | 9 | 9 |
Capitalised transaction costs | (1) | 0 | (1) |
Borrowings | 1,949 | 149 | 1,800 |
Interest terms fixed until | Effective annual interest rate | Currency | 31.12.2024 Carrying amount in € million | Interest terms fixed until | Effective annual interest rate | Currency | 31.12.2023 Carrying amount in € million |
2025 | EURIBOR + margin | EUR | 444 | 2024 | EURIBOR + margin | EUR | 573 |
0.50% | EUR | 150 | 3.10% | EUR | 35 | ||
Various - Variable rate | Various | 35 | Various - Variable rate | Various | 34 | ||
2026 | 3.61% | EUR | 264 | 2025 | 0.50% | EUR | 150 |
2027 | 2.41% | EUR | 715 | 2026 | 3.63% | EUR | 264 |
2028 | 1.87% | EUR | 119 | 2027 | 2.44% | EUR | 744 |
2029 | 1.52% | EUR | 8 | 2028 | 1.90% | EUR | 119 |
2031 | 1.25% | EUR | 5 | 2029 | 1.52% | EUR | 8 |
2031 | 1.28% | EUR | 5 | ||||
1,740 | 1,932 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
31.12.2024 | 31.12.2023 | |||||
in € million | Current | Non-current | Total | Current | Non-current | Total |
Forward exchange contracts | 1 | 0 | 1 | 1 | 0 | 1 |
Interest rate derivatives | 0 | 4 | 4 | 0 | 2 | 2 |
Commodity swaps | 2 | 3 | 5 | 1 | 10 | 11 |
Derivatives in open orders | 0 | 0 | 0 | 3 | 0 | 3 |
Derivative financial liabilities | 3 | 7 | 10 | 5 | 12 | 17 |
Lease liabilities | 17 | 60 | 77 | 18 | 52 | 70 |
Fixed-term or puttable non-controlling interests | 7 | 45 | 52 | 18 | 69 | 87 |
Other financial liabilities | 27 | 112 | 139 | 41 | 133 | 174 |
in € million | Ownership interest held by NCI | 31.12.2024 | 31.12.2023 |
Horn & Co. Minerals Recovery GmbH & Co.KG | 45.00% | 4 | 8 |
RHI Magnesita Czech Republic a.s. | 3.13% | 1 | 0 |
RHI Magnesita (Chongqing) Refractory Materials Co., Ltd. | 49.00% | 11 | 15 |
Jinan New Emei Industries Co. Ltd. | 35.00% | 21 | 30 |
Liaoning RHI Jinding Magnesia Co., Ltd. | 16.67% | 4 | 23 |
RHI Refractories Liaoning Co., Ltd. | 34.00% | 11 | 11 |
Liabilities to fixed-term or puttable non-controlling interests | 52 | 87 |
in € million | 31.12.2024 | 31.12.2023 |
Liabilities at beginning of the year | 87 | 68 |
Currency translation1) | 2 | (5) |
Interest accrued2) | (1) | 7 |
Remeasurement gains2) | (21) | (7) |
Dividends paid | (6) | (8) |
Additions | 1 | 0 |
Additions from initial consolidation | 0 | 32 |
Derecognition related to Liaoning RHI Jinding Magnesia Co., Ltd. | (10) | 0 |
Liabilities at year-end | 52 | 87 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Financial liabilities increase by | Financial liabilities decrease by |
Profit measure increases by 15% | 6 | |
Profit measure decreases by 15% | 6 |
in € million | 31.12.2024 | 31.12.2023 |
Present value of pension obligations | 377 | 421 |
Fair value of plan assets | (182) | (186) |
Deficit of funded plans | 195 | 235 |
Asset ceiling | 5 | 5 |
Net liability from pension obligations | 200 | 240 |
Overfunded pension plans | (1) | (2) |
Other pension plans | 201 | 242 |
in € million | 31.12.2024 | 31.12.2023 |
Active beneficiaries | 62 | 62 |
Vested terminated beneficiaries | 41 | 44 |
Retirees | 274 | 315 |
Present value of pension obligations | 377 | 421 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in % | 31.12.2024 | 31.12.2023 |
Interest rate | ||
Austria and Germany | 3.4% | 3.3% |
Brazil | 12.2% | 10.1% |
United Kingdom | 5.5% | 4.5% |
USA | 5.5% | 4.8% |
Future salary increase | ||
Austria | 2.7% | 3.9% |
Germany | 2.5% | 2.5% |
Brazil | 5.8% | 4.5% |
United Kingdom1) | n/a | n/a |
USA | 3.3% | 3.3% |
Future pension increase | ||
Austria | 3.3% | 5.3% |
Germany | 2.0% | 2.2% |
Brazil | 4.3% | 4.5% |
United Kingdom | 3.1% | 3.0% |
USA | 2.0% | 2.0% |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Net liability from pension obligations at beginning of year | 240 | 213 |
Currency translation | (5) | 2 |
Additions initial consolidation | 0 | 11 |
Pension cost | 12 | 12 |
Remeasurement (gains)/losses | (25) | 23 |
Benefits paid | (19) | (17) |
Employers' contributions to external funds | (3) | (4) |
Net liability from pension obligations at year-end | 200 | 240 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Present value of pension obligations at beginning of year | 421 | 396 |
Currency translation | (5) | 4 |
Additions initial consolidation | 0 | 11 |
Current service cost | 2 | 2 |
Interest cost | 18 | 19 |
Remeasurement losses/(gains) | ||
from changes in demographic assumptions | 0 | (1) |
from changes in financial assumptions | (25) | 28 |
due to experience adjustments | (3) | (3) |
Benefits paid | (32) | (35) |
Employee contributions to external funds | 1 | 1 |
Plan amendments | 0 | (1) |
Present value of pension obligations at year-end | 377 | 421 |
in € million | 2024 | 2023 |
Fair value of plan assets at beginning of year | 186 | 187 |
Currency translation | 0 | 1 |
Interest income | 9 | 9 |
(Losses)/gains on plan assets less interest income | (3) | 3 |
Benefits paid | (14) | (19) |
Employers' contributions to external funds | 3 | 4 |
Employee contributions to external funds | 1 | 1 |
Fair value of plan assets at year-end | 182 | 186 |
in € million | 2024 | 2023 |
Asset ceiling at beginning of year | 5 | 4 |
Losses from changes in asset ceiling less interest expense | 0 | 1 |
Asset ceiling at year-end | 5 | 5 |
in € million | 2024 | 2023 |
Current service cost | 2 | 2 |
Interest cost | 19 | 19 |
Interest income | (9) | (9) |
Pension expense recognised in profit or loss | 12 | 12 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Accumulated remeasurement losses at beginning of year | 118 | 95 |
Remeasurement (gains)/losses on present value of pension obligations | (28) | 24 |
Losses/(gains) on plan assets less interest income | 3 | (2) |
Losses from changes in asset ceiling less interest expense | 0 | 1 |
Accumulated remeasurement losses at year-end | 93 | 118 |
31.12.2024 | 31.12.2023 | |||||
in € million | Active market | No active market | Total | Active market | No active market | Total |
Insurances | 0 | 73 | 73 | 22 | 55 | 77 |
Equity instruments | 46 | 0 | 46 | 40 | 0 | 40 |
Debt instruments | 41 | 1 | 42 | 44 | 0 | 44 |
Cash and cash equivalents | 12 | 0 | 12 | 9 | 1 | 10 |
Other assets | 9 | 0 | 9 | 15 | 0 | 15 |
Fair value of plan assets | 108 | 74 | 182 | 130 | 56 | 186 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
31.12.2024 | 31.12.2023 | ||||
in € million | Change of assumption in percentage points or years | Pension plans | Termination benefits | Pension plans | Termination benefits |
Present value of the obligations | 377 | 39 | 421 | 36 | |
Interest rate | +0.25 | (9) | (1) | (10) | (1) |
(0.25) | 10 | 1 | 10 | 1 | |
Salary increase | +0.25 | 1 | 1 | 1 | 1 |
(0.25) | (1) | (1) | 0 | (1) | |
Pension increase | +0.25 | 6 | 8 | ||
(0.25) | (7) | (7) | |||
Life expectancy | + 1 year | 6 | 3 | ||
(1) year | (5) | (2) | |||
in € million | 31.12.2024 | 31.12.2023 |
Termination benefits | 35 | 34 |
Service anniversary bonuses | 20 | 19 |
Semi-retirements | 4 | 2 |
Other personnel provisions | 59 | 55 |
in % | 31.12.2024 | 31.12.2023 |
Interest rate | 3.4% | 3.3% |
Future salary increase | 3.4% | 3.3% |
in € million | 2024 | 2023 |
Provisions for termination benefits at beginning of year | 34 | 32 |
Additions initial consolidation | 0 | 2 |
Current service cost | 1 | 2 |
Interest cost | 1 | 1 |
Remeasurement losses | 1 | 0 |
Benefits paid | (2) | (3) |
Provisions for termination benefits at year-end | 35 | 34 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Accumulated remeasurement losses at beginning of year | 18 | 18 |
Remeasurement losses | 1 | 0 |
Accumulated remeasurement losses at year-end | 19 | 18 |
in € million | 31.12.2024 | 31.12.2023 |
Present value of semi-retirement obligations | 5 | 4 |
Fair value of plan assets | (1) | (1) |
Provisions for semi-retirement obligations | 4 | 3 |
in € million | Onerous/unfavourable contracts | Labour and civil contingencies | Demolition/disposal costs, environmental damages | Restructuring costs | Other | Total |
31.12.2023 | 67 | 11 | 30 | 9 | 9 | 126 |
Currency translation | (9) | (2) | (1) | 0 | 0 | (12) |
Reversals | (6) | (3) | (2) | 0 | (3) | (14) |
Additions | 2 | 3 | 6 | 16 | 3 | 30 |
Additions interest | 5 | 1 | 1 | 0 | 0 | 7 |
Use | (13) | (2) | (1) | (5) | (3) | (24) |
Reclassifications | 0 | 0 | 0 | 0 | 1 | 1 |
31.12.2024 | 46 | 8 | 33 | 20 | 7 | 114 |
non-current | 35 | 8 | 28 | 0 | 0 | 71 |
current | 11 | 0 | 5 | 20 | 7 | 43 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | Onerous/unfavourable contracts | Labour and civil contingencies | Demolition/disposal costs, environmental damages | Restructuring costs | Other | Total |
31.12.2022 | 62 | 9 | 23 | 12 | 4 | 110 |
Currency translation | 3 | 0 | 0 | 0 | 0 | 3 |
Reversals | (2) | (3) | (1) | (1) | (1) | (8) |
Additions | 11 | 6 | 8 | 3 | 7 | 35 |
Additions interest | 6 | 1 | 1 | 0 | 0 | 8 |
Use | (13) | (2) | (1) | (5) | (1) | (22) |
Reclassifications | 0 | 0 | 0 | 0 | 0 | 0 |
31.12.2023 | 67 | 11 | 30 | 9 | 9 | 126 |
non-current | 52 | 11 | 28 | 0 | 0 | 91 |
current | 15 | 0 | 2 | 9 | 9 | 35 |
in € million | 31.12.2024 | 31.12.2023 |
Trade payables | 455 | 414 |
Trade payables subject to supplier finance arrangements | 117 | 84 |
Contract liabilities | 59 | 65 |
Liabilities to employees | 111 | 136 |
Taxes other than income tax | 31 | 33 |
Capital expenditure payable | 22 | 33 |
Payables from commissions | 10 | 9 |
Other current liabilities | 38 | 46 |
Trade payables and other current liabilities | 843 | 820 |
thereof financial liabilities | 619 | 561 |
thereof non-financial liabilities | 224 | 259 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 | |
Profit after income tax | 154 | 171 | |
Adjustments for | |||
income tax | 46 | 62 | |
depreciation | 136 | 134 | |
amortisation | 39 | 44 | |
impairment of property, plant and equipment and intangible assets | 42 | 1 | |
(income) / expense from financial assets excluding trade and other receivables | 3 | (23) | |
(gains)/losses from the disposal of property, plant and equipment | (5) | 4 | |
(gains)/losses from the disposal of foreign operations | (8) | 1 | |
net interest expense, interest rate derivatives and remeasurement of liabilities to the fixed-term or puttable non-controlling interest | 43 | 63 | |
other non-cash changes | (10) | 42 | |
Changes in working capital | |||
inventories | 25 | 183 | |
trade receivables | 2 | 2 | |
trade payables | 83 | (118) | |
contract liabilities | (5) | (14) | |
Changes in other assets and liabilities | |||
other receivables and assets | 7 | 13 | |
provisions | (28) | (25) | |
other liabilities | (22) | 25 | |
Cash generated from operations | 502 | 565 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Cash changes | Non-cash changes | ||||||||
in € million | 31.12.2023 | Changes in foreign exchange rates | Interest and other fair value changes | Reclassifications | Additions from initial consolidation | Additions and modifications of leases (IFRS 16) | 31.12.2024 | ||
Borrowings | (1,949) | 201 | (1) | (1) | 0 | 0 | 0 | (1,750) | |
Lease liabilities | (70) | 20 | 2 | 0 | 0 | 0 | (29) | (77) | |
Cash and cash equivalents | 704 | (130) | 2 | 0 | 0 | 0 | 0 | 576 | |
Marketable securities | 11 | (10) | (1) | 0 | 0 | 0 | 0 | 0 | |
Net debt | (1,304) | 81 | 2 | (1) | 0 | 0 | (29) | (1,251) | |
Liabilities to fixed-term or puttable non-controlling interests1) | (87) | 6 | (2) | 22 | 9 | 0 | 0 | (52) | |
Cash changes | Non-cash changes | ||||||||
in € million | 31.12.2022 | Changes in foreign exchange rates | Interest and other fair value changes | Reclassifications | Additions from initial consolidation | Additions and modifications of leases (IFRS 16) | 31.12.2023 | ||
Borrowings | (1,620) | (257) | 1 | 1 | 0 | (74) | 0 | (1,949) | |
Lease liabilities | (64) | 23 | 1 | (3) | 0 | (12) | (15) | (70) | |
Cash and cash equivalents | 521 | 196 | (4) | 0 | (9) | 0 | 0 | 704 | |
Marketable securities | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 11 | |
Net debt | (1,163) | (27) | (2) | (2) | (9) | (86) | (15) | (1,304) | |
Liabilities to fixed-term or puttable non-controlling interests1) | (68) | 8 | 5 | 0 | 0 | (32) | 0 | (87) | |
in € million | Cash flow hedge | At fair value through profit or loss | At fair value through OCI | At amortised cost | Not a financial instrument | Book value as of 31.12.2024 | Fair value as of 31.12.2024 |
Financial assets | |||||||
Non-current financial assets | 12 | 15 | 7 | 8 | 0 | 42 | 42 |
Trade and other receivables | 0 | 0 | 46 | 487 | 127 | 660 | 660 |
Current financial assets | 13 | 4 | 0 | 0 | 0 | 17 | 17 |
Cash and cash equivalents | 0 | 0 | 0 | 576 | 0 | 576 | 576 |
25 | 19 | 53 | 1,071 | 127 | 1,295 | 1,295 | |
Financial liabilities | |||||||
Borrowings | 0 | 0 | 0 | 1,750 | 0 | 1,750 | 1,737 |
Other financial liabilities | 9 | 38 | 0 | 92 | 0 | 139 | 139 |
Trade payables and other liabilities | 0 | 0 | 0 | 619 | 224 | 843 | 843 |
9 | 38 | 0 | 2,461 | 224 | 2,732 | 2,719 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Cash flow hedge | At fair value through profit or loss | At fair value through OCI | At amortised cost | Not a financial instrument | Book value as of 31.12.2023 | Fair value as of 31.12.2023 |
Financial assets | |||||||
Non-current financial assets | 21 | 14 | 5 | 3 | 0 | 43 | 43 |
Trade and other receivables | 0 | 0 | 31 | 510 | 139 | 681 | 681 |
Current financial assets | 0 | 12 | 0 | 2 | 0 | 14 | 14 |
Cash and cash equivalents | 0 | 0 | 0 | 704 | 0 | 704 | 704 |
21 | 26 | 36 | 1,219 | 139 | 1,441 | 1,441 | |
Financial liabilities | |||||||
Borrowings | 0 | 0 | 0 | 1,949 | 0 | 1,949 | 1,937 |
Other financial liabilities | 13 | 58 | 0 | 103 | 0 | 174 | 174 |
Trade payables and other liabilities | 0 | 0 | 0 | 561 | 259 | 820 | 820 |
13 | 58 | 0 | 2,613 | 259 | 2,943 | 2,931 |
31.12.2024 | 31.12.2023 | |||||||
in € million | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
Assets | ||||||||
Non-current financial assets | 12 | 12 | 8 | 32 | 12 | 20 | 5 | 37 |
Current financial assets | 0 | 16 | 0 | 16 | 11 | 1 | 0 | 12 |
Liabilities | ||||||||
Borrowings | 0 | 1,727 | 0 | 1,727 | 0 | 1,920 | 0 | 1,920 |
Other financial liabilities | 0 | 10 | 52 | 62 | 0 | 17 | 87 | 104 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Net gain from financial assets and liabilities measured at fair value through profit or loss | 5 | 18 |
Net (loss) from financial assets and liabilities measured at amortised cost | (1) | (4) |
31.12.2024 | 31.12.2023 | |||||
in € million | Current | Non-current | Total | Current | Non-current | Total |
Marketable securities and shares | 0 | 20 | 20 | 11 | 17 | 28 |
Interest rate derivatives and commodity swaps | 0 | 12 | 12 | 0 | 21 | 21 |
Restricted cash | 0 | 8 | 8 | 0 | 3 | 3 |
Other interests | 0 | 2 | 2 | 0 | 2 | 2 |
Loans | 0 | 0 | 0 | 2 | 0 | 2 |
Derivatives in open orders and forward exchange contracts | 17 | 0 | 17 | 1 | 0 | 1 |
Other financial assets | 17 | 42 | 59 | 14 | 43 | 57 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Carrying amount | Statement of Financial Position | Change in fair value recognised in Other Comprehensive Income | Nominal amount |
2024 | 6 | Other non-current financial assets (liabilities) | 6 | EUR 1,052 million |
2023 | 18 | Other non-current financial assets (liabilities) | (15) | EUR 1,081 million |
in € million | Cash flow hedge reserve within Equity | Balance net of deferred tax |
2024 | 6 | 5 |
2023 | 18 | 14 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | Carrying amount | Statement of Financial Position | Change in fair value recognised in Other Comprehensive Income | Nominal amount |
2024 | (3) | Other current and non-current financial assets (liabilities) | 8 | Gas 1,536 GWh Oil 624,033 bbl Power 117 GWh |
2023 | (11) | Other current and non-current financial assets (liabilities) | (11) | Gas 1,141 GWh Oil 700,297 bbl Power 30 GWh |
in € million | Cash flow hedge reserve within Equity | Balance net of deferred tax |
2024 | (3) | (2) |
2023 | (11) | (8) |
31.12.2024 | |||
Hedging instrument | up to 1 year | 1 to 5 years | |
Commodity swaps - gas | Notional amount (Gwh) | 214 | 1,322 |
Average hedged price per MWh | 53.15 | 34.93 | |
Commodity swaps - oil | Notional amount (bbl) | 346,342 | 277,691 |
Average hedged price per bbl | 75.14 | 73.47 | |
Commodity swaps - power | Notional amount (Gwh) | 117 | |
Average hedged price per MWh | 72.10 |
31.12.2023 | |||
Hedging instrument | up to 1 year | 1 to 5 years | |
Commodity swaps - gas | Notional amount (Gwh) | 20 | 1,121 |
Average hedged price per MWh | 58.40 | 40.17 | |
Commodity swaps - oil | Notional amount (bbl) | 406,324 | 293,973 |
Average hedged price per bbl | 76.67 | 75.28 | |
Commodity swaps - power | Notional amount (Gwh) | 30 | |
Average hedged price per MWh | 89.45 |
Notes to the Consolidated Financial Statements 2024 | ||||
31.12.2024 | ||||
Purchase | Sale | Nominal in | Nominal value in million | Fair value in € million |
MXN | USD | MXN | 420 | 0 |
EUR | USD | USD | 75 | 0 |
USD | INR | USD | 15 | 0 |
EUR | ZAR | ZAR | 175 | 0 |
USD | BRL | USD | 7 | 0 |
CLP | USD | USD | 17 | 0 |
EUR | INR | EUR | 26 | 0 |
CZK | EUR | EUR | 11 | (1) |
Forward exchange contracts | (1) | |||
31.12.2023 | ||||
Purchase | Sale | Nominal in | Nominal value in million | Fair value in € million |
EUR | ZAR | ZAR | 175 | 0 |
MXN | USD | MXN | 670 | 0 |
USD | INR | USD | 20 | 0 |
EUR | USD | USD | 150 | (1) |
BRL | USD | USD | 30 | 0 |
CLP | USD | USD | 19 | 0 |
EUR | INR | EUR | 33 | 0 |
CZK | EUR | EUR | 16 | 0 |
Forward exchange contracts | (1) | |||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 31.12.2024 | 31.12.2023 |
Trade receivables and contract assets - gross | 533 | 542 |
Credit insurance and letters of credit | (258) | (235) |
Trade receivables and contract assets - net | 275 | 307 |
2024 | 2023 | |||
in € million | Individually assessed - credit impaired | Collectively assessed - not credit impaired | Individually assessed - credit impaired | Collectively assessed - not credit impaired |
Accumulated valuation allowance at beginning of year | 52 | 1 | 29 | 1 |
Currency translation | (2) | 0 | 0 | 0 |
Additions initial consolidation | 0 | 0 | 9 | 0 |
Addition | 3 | 0 | 19 | 0 |
Use | (2) | 0 | (4) | 0 |
Reversal | (4) | 0 | (1) | 0 |
Accumulated valuation allowance at year-end | 47 | 1 | 52 | 1 |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | Trade receivables and contract assets | ||||||
31.12.2024 | not past due | less than 30 days | more than 31 days | Collectively assessed - not credit impaired | Individually assessed - credit impaired | Total | |
Expected credit loss rate in % | 0.03 - 0.54% | 0.09-1.24% | 0.77 - 85.52% | ||||
Gross carrying amount invoiced | 371 | 25 | 19 | 416 | 122 | 538 | |
Lifetime expected credit loss | (1) | 0 | 0 | (1) | (1) | ||
Valuation allowance - credit impaired | (47) | (47) | |||||
Carrying amount with either expected credit loss or incurred loss allowance | 490 | ||||||
Carrying amount without expected credit loss or incurred loss allowance | 43 | ||||||
Total trade receivables and contract assets | 533 | ||||||
in € million | Trade receivables and contract assets | |||||
31.12.2023 | not past due | less than 30 days | more than 31 days | Collectively assessed - not credit impaired | Individually assessed - credit impaired | Total |
Expected credit loss rate in % | 0.01 - 0.57% | 0.05-1.22% | 0.30 - 59.13% | |||
Gross carrying amount invoiced | 414 | 28 | 17 | 459 | 90 | 549 |
Lifetime expected credit loss | (1) | 0 | 0 | (1) | (1) | |
Valuation allowance - credit impaired | (52) | (52) | ||||
Carrying amount with either expected credit loss or incurred loss allowance | 496 | |||||
Carrying amount without expected credit loss or incurred loss allowance | 46 | |||||
Total trade receivables and contract assets | 542 | |||||
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Borrowings | |||||
fixed interest | 403 | 417 | 157 | 252 | 8 |
variable interest | 1,337 | 1,466 | 167 | 1,269 | 30 |
Other financial liabilities | 10 | 10 | 1 | 9 | 0 |
Lease liabilities | 77 | 87 | 19 | 41 | 27 |
Liabilities to fixed-term or puttable non-controlling interests | 52 | 84 | 7 | 27 | 50 |
Trade payables and other current liabilities | 619 | 619 | 619 | 0 | 0 |
Non-derivative financial liabilities | 2,498 | 2,683 | 970 | 1,598 | 115 |
Borrowings | |||||
fixed interest | 433 | 455 | 49 | 391 | 15 |
variable interest | 1,499 | 1,736 | 154 | 1,364 | 218 |
Other financial liabilities | 17 | 23 | 14 | 9 | 0 |
Lease liabilities | 70 | 77 | 18 | 34 | 25 |
Liabilities to fixed-term or puttable non-controlling interests | 87 | 181 | 18 | 13 | 150 |
Trade payables and other current liabilities | 561 | 561 | 561 | 0 | 0 |
Non-derivative financial liabilities | 2,667 | 3,033 | 814 | 1,811 | 408 |
Remaining term | |||||
in € million | Carrying amount 31.12.2024 | Cash flows | up to 1 year | 1 to 5 years | over 5 years |
Receivables from derivatives with net settlement | |||||
Interest rate swaps | 10 | 10 | 0 | 10 | 0 |
Commodity swaps | 2 | 2 | 0 | 2 | 0 |
Forward exchange contracts | 14 | 14 | 14 | 0 | 0 |
Derivatives in open orders | 3 | 3 | 3 | 0 | 0 |
Liabilities from derivatives with net settlement | |||||
Commodity swaps | 5 | 5 | 2 | 3 | 0 |
Interest rate derivatives | 4 | 4 | 0 | 4 | 0 |
Forward exchange contracts | 1 | 1 | 1 | 0 | 0 |
Notes to the Consolidated Financial Statements 2024 | ||||
Remaining term | |||||
in € million | Carrying amount 31.12.2023 | Cash flows | up to 1 year | 1 to 5 years | over 5 years |
Receivables from derivatives with net settlement | |||||
Interest rate derivatives | 20 | 20 | 0 | 20 | 0 |
Commodity swaps | 1 | 1 | 1 | 0 | 0 |
Forward exchange contracts | 0 | 0 | 0 | 0 | 0 |
Liabilities from derivatives with net settlement | |||||
Commodity swaps | 11 | 11 | 1 | 10 | 0 |
Derivatives in open orders | 3 | 3 | 3 | 0 | 0 |
Interest rate derivatives | 2 | 2 | 0 | 1 | 1 |
Forward exchange contracts | 1 | 1 | 1 | 0 | 0 |
31.12.2024 in € million | USD | EUR | ZAR | TRY | Other | Total |
Financial assets | 579 | 82 | 11 | 22 | 15 | 709 |
Financial liabilities, provisions | (426) | (44) | 0 | (6) | (20) | (496) |
Net foreign currency position | 153 | 38 | 11 | 16 | (5) | 213 |
31.12.2023 in € million | USD | EUR | GBP | INR | Other | Total |
Financial assets | 729 | 60 | 8 | 3 | 48 | 848 |
Financial liabilities, provisions | (470) | (95) | (15) | (1) | (22) | (603) |
Net foreign currency position | 259 | (35) | (7) | 2 | 26 | 245 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Appreciation of 10% | Devaluation of 10% | |||
31.12.2024 in € million | (Loss)/gain | Equity | Gain/(loss) | Equity |
USD | (14) | (14) | 17 | 17 |
EUR | (3) | 1 | 4 | (1) |
ZAR | (1) | (1) | 1 | 1 |
TRY | (1) | (1) | 2 | 2 |
Other currencies | 0 | 0 | (1) | (1) |
Appreciation of 10% | Devaluation of 10% | |||
31.12.2023 in € million | (Loss)/gain | Equity | Gain/(loss) | Equity |
USD | (22) | (20) | 27 | 25 |
EUR | 2 | 6 | (2) | (7) |
Other currencies | (2) | (2) | 2 | 2 |
Notes to the Consolidated Financial Statements 2024 | ||||
31.12.2024 | 31.12.2023 | |
Net debt (in € million)1) | 1,251 | 1,304 |
Net gearing ratio (in %) | 91.2% | 95.6% |
Net debt to Adjusted EBITDA | 2.30x | 2.40x |
in € million | 31.12.2024 | 31.12.2023 |
EBIT | 242 | 333 |
Amortisation | 40 | 44 |
Restructuring and write-down expenses | 24 | 20 |
Other operating income and expenses | 101 | 12 |
Adjusted EBITA | 407 | 409 |
Depreciation | 136 | 134 |
Adjusted EBITDA | 543 | 543 |
Total debt | 1,750 | 1,949 |
Lease liabilities | 77 | 70 |
Less: Cash and cash equivalents | 576 | 704 |
Less: Marketable securities | 0 | 11 |
Net debt | 1,251 | 1,304 |
Net debt excluding IFRS 16 lease liabilities | 1,174 | 1,234 |
Net debt to Adjusted EBITDA | 2.30x | 2.40x |
Net debt to Adjusted EBITDA excluding IFRS 16 lease liabilities | 2.16x | 2.27x |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
Notes to the Consolidated Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
Fees in respect of the audit of the Consolidated and Parent Company Financial Statements1) | (1) | (1) |
Other audit fees, in respect of subsidiaries' audit, to PwC network firms | (2) | (2) |
Total audit fees | (3) | (3) |
Other non-audit services1)2) | (1) | (1) |
Total fees | (4) | (4) |
Joint ventures | ||
in € million | 2024 | 2023 |
Revenue from the sale of goods and services | 2 | 2 |
Purchase of raw materials | 6 | 6 |
Trade liabilities | 0 | 1 |
Notes to the Consolidated Financial Statements 2024 Financial Statements 2024 Continued |
in € million | 2024 | 2023 |
Executive Directors and EMT | ||
Short-term employee benefits | 9 | 10 |
Share-based payments | 4 | 6 |
Total | 13 | 16 |
Non-Executive Directors1) | 2 | 1 |
Company Financial Statements of RHI Magnesita N.V. | ||||
in € million | Note | 31.12.2024 | 31.12.2023 |
ASSETS | |||
Non-current assets | |||
Non-current financial assets | (A) | 1,193 | 1,196 |
Securities | 1 | 1 | |
Deferred tax assets | 11 | 7 | |
Total non-current assets | 1,205 | 1,204 | |
Current assets | |||
Receivables from group companies | 1 | 9 | |
Other current receivables | 4 | 1 | |
Cash and cash equivalents | (B) | 0 | 1 |
Total current assets | 5 | 11 | |
Total assets | 1,210 | 1,215 | |
EQUITY AND LIABILITIES | |||
Equity | |||
Share capital | (C) | 50 | 50 |
Treasury shares | (D) | (108) | (111) |
Additional paid-in capital | (E) | 361 | 361 |
Legal and mandatory reserves | (F) | 86 | 86 |
Other reserves | 671 | 651 | |
Result for the period | (J) | 142 | 165 |
Shareholders' Equity | 1,202 | 1,202 | |
Current liabilities | |||
Current liabilities | (G) | 8 | 13 |
Total liabilities | 8 | 13 | |
Total equity and liabilities | 1,210 | 1,215 |
Company Financial Statements of RHI Magnesita N.V. As at 31 December 2024 | ||||
in € million | Note | 2024 | 2023 |
General and administrative expenses | (H) | (25) | (30) |
Result before taxation | (25) | (30) | |
Loss before income tax | (25) | (30) | |
Income tax | 3 | (3) | |
Net result from investments | (I) | 164 | 198 |
Net result for the period | (J) | 142 | 165 |
Legal and mandatory reserves | Other reserves | |||||||||
in € million | Share capital | Treasury shares | Additional paid-in capital | Cash flow hedges | Currency translation | Mandatory reserve | Retained earnings | Net result | Equity attributable to shareholders | |
31.12.2023 | 50 | (111) | 361 | 6 | (163) | 289 | 605 | 165 | 1,202 | |
Appropriation of prior year result | - | - | - | - | - | - | 165 | (165) | - | |
Net result | - | - | - | - | - | - | - | 142 | 142 | |
Share transfer / Vested LTIP | - | 3 | - | - | - | - | (3) | - | - | |
Share-based expenses | - | - | - | - | - | - | 9 | - | 9 | |
Dividends | - | - | - | - | - | - | (87) | - | (87) | |
Net income / (expense) recognised directly in equity | - | - | - | 6 | (91) | - | 21 | - | (64) | |
31.12.2024 | 50 | (108) | 361 | 12 | (254) | 289 | 710 | 142 | 1,202 | |
Legal and mandatory reserves | Other reserves | |||||||||
in € million | Share capital | Treasury shares | Additional paid-in capital | Cash flow hedges | Currency translation | Mandatory reserve | Retained earnings | Net result | Equity attributable to shareholders | |
31.12.2022 | 50 | (116) | 361 | 32 | (148) | 289 | 378 | 156 | 1,002 | |
Appropriation of prior year result | - | - | - | - | - | - | 156 | (156) | - | |
Net result | - | - | - | - | - | - | - | 165 | 165 | |
Share transfer / Vested LTIP | - | 5 | - | - | - | - | (5) | - | - | |
Share-based expenses | - | - | - | - | - | - | 9 | - | 9 | |
Dividends | - | - | - | - | - | - | (78) | - | (78) | |
Net income / (expense) recognised directly in equity | - | - | - | (26) | (15) | - | 145 | - | 104 | |
31.12.2023 | 50 | (111) | 361 | 6 | (163) | 289 | 605 | 165 | 1,202 | |
Notes to the CompanY Financial Statements 2024 | ||||
Notes to the Company Financial Statements 2024Continued |
31.12.2024 | 31.12.2023 | ||
Name and country of incorporation of the company | Country of core activity | Share in % | Share in % |
RHI Magnesita Deutschland AG, Wiesbaden, Germany | Germany | 12.5 | 12.5 |
RHI Refractories Raw Material GmbH, Vienna, Austria | Austria | 25.0 | 25.0 |
RHI Magnesita GmbH, Vienna, Austria | Austria | 100.0 | 100.0 |
in € million | 2024 | 2023 |
At beginning of year | 1,196 | 943 |
Transactions with non-controlling interests without change of control | 5 | 161 |
Changes from currency translation and cash flow hedges | (84) | (40) |
Changes from defined benefit plans | 16 | (16) |
Dividend distribution | (104) | (50) |
Net result from investments | 164 | 198 |
Balance at year-end | 1,193 | 1,196 |
Notes to the CompanY Financial Statements 2024 | ||||
31.12.2024 | 31.12.2023 | ||||
Ser. no. | Name and country of incorporation of the company | Share- holder | Share in % | Share- holder | Share in % |
1. | RHI Magnesita N.V., Arnhem, Netherlands | ||||
2. | Agellis Group AB, Lund, Sweden | 32. | 100.0 | 32. | 100.0 |
3. | Baker Refractories Holding Company, Delaware, USA | 22. | 100.0 | 22. | 100.0 |
4. | Baker Refractories I.C., Inc., Delaware, USA | 3. | 100.0 | 3. | 100.0 |
5. | Didier Société Industrielle de Production et de Construction - "D.S.I.P.C.", Valenciennes, France | 47. | 100.0 | 47. | 100.0 |
6. | Dutch Brasil Holding B.V., Arnhem, Netherlands | 90. | 100.0 | 90. | 100.0 |
7. | Dutch MAS B.V., Arnhem, Netherlands | 47. | 100.0 | 47. | 100.0 |
8. | Dutch US Holding B.V., Arnhem, Netherlands | 90. | 100.0 | 90. | 100.0 |
9. | Foreign Enterprise “VERA", Dnepropetrovsk, Ukraine | 32. | 100.0 | 32. | 100.0 |
10. | GIX International Limited, Dinnington, United Kingdom | 94. | 100.0 | 94. | 100.0 |
11. | Horn & Co. RHIM Minerals Recovery GmbH, Siegen, Germany | 48. | 55.0 | 48. | 51.0 |
12. | Intermetal Engineers (India) Private Limited, Mumbai, India | 49. | 100.0 | 49. | 100.0 |
13. | Jinan New Emei Industries Co. Ltd., Jinan, China | 43. | 65.0 | 43. | 65.0 |
14. | Liaoning RHI Jinding Magnesia Co., Ltd, Dashiqiao, China1) | 32. | 100.0 | 32. | 100.0 |
15. | Lokalbahn Mixnitz-St. Erhard GmbH, Vienna, Austria | 69. | 100.0 | 69. | 100.0 |
16. | LWB Refractories Holding France S.A.S., Valenciennes, France 3) | 33. | 100.0 | n/a | 100.0 |
17. | Magnesita Asia Refractory Holding, Limited, Hong Kong, Hong Kong | 16. | 100.0 | 16. | 100.0 |
18. | Magnesita Malta Finance Ltd., St. Julians, Malta 3) | 19. | 100.0 | n/a | 100.0 |
19. | Magnesita Malta Holding Ltd., St. Julians, Malta 3) | 48. | 100.0 | n/a | 100.0 |
20. | Magnesita Mineração S.A., Brumado, Brazil | 28. | 100.0 | 28. | 100.0 |
21. | Magnesita Refractories (Dalian) Co., Ltd., Dalian, China 3) | 43. | 100.0 | n/a | 100.0 |
22. | Magnesita Refractories Company, York, USA | 33. | 100.0 | 33. | 100.0 |
23. | Magnesita Refractories Limited, Dinnington, United Kingdom | 3. | 100.0 | 3. | 100.0 |
24. | Magnesita Refractories México, S.A. de C.V., Monterrey, Mexico | 3.,4. | 100.0 | 3.,4. | 100.0 |
25. | Magnesita Refractories Middle East Free Zone Establishment, Dubai, United Arab Emirates 3) | 6. | 100.0 | n/a | 100.0 |
26. | Magnesita Refractories S.C.S., Valenciennes, France 3) | 16.,33. | 100.0 | n/a | 100.0 |
27. | Magnesita Refractories S.R.L., Milano, Italy 3) | 33. | 100.0 | n/a | 100.0 |
28. | Magnesita Refratários S.A., Contagem, Brazil | 6. | 100.0 | 6. | 100.0 |
29. | Magnesita Resource (Anhui) Company Ltd., Chizhou, China | 43. | 100.0 | 43. | 100.0 |
30. | P-D Refractories CZ a.s., Velké Opatovice, Czech Republic | 48. | 96.9 | 48. | 86.8 |
31. | Producción RHI México, S. de R.L. de C.V., Ramos Arizpe, Mexico | 64.,94. | 100.0 | 64.,94. | 100.0 |
32. | Radex Vertriebsgesellschaft m.b.H., Leoben, Austria | 92. | 100.0 | 92. | 100.0 |
33. | Rearden G Holdings Eins GmbH, Wiesbaden, Germany 3) | 6. | 100.0 | n/a | 100.0 |
34. | Refractarios Argentinos S.A, Industrial Comercial Y Minera (I.C.M.), San Nicolás, Argentina | 6.,8.,94. | 100.0 | 6.,8.,94. | 100.0 |
35. | Refractarios Magnesita Colombia S.A.S., Sogamoso, Colombia | 6. | 100.0 | 6. | 100.0 |
36. | Refractarios Magnesita Perú S.A.C., Lima, Peru | 6. | 100.0 | 6. | 100.0 |
37. | Refractory Intellectual Property GmbH, Vienna, Austria | 48. | 100.0 | 48. | 100.0 |
38. | Refractory Intellectual Property GmbH & Co KG, Vienna, Austria | 37. | 100.0 | 37. | 100.0 |
39. | Refrattari Trezzi S.r.l., Merlino, Italy | 11. | 100.0 | - | 0.0 |
40. | RHI Canada Inc., Burlington, Canada | 94. | 100.0 | 94. | 100.0 |
Notes to the Company Financial Statements 2024Continued |
31.12.2024 | 31.12.2023 | ||||
Ser. no. | Name and country of incorporation of the company | Share- holder | Share in % | Share- holder | Share in % |
41. | RHI Chile S.A., Santiago, Chile | 10.,34.,94. | 100.0 | 10.,34.,94. | 100.0 |
42. | RHI Italia S.R.L., Brescia, Italy | 48. | 100.0 | 48. | 100.0 |
43. | RHI Magnesita (China) Co., Ltd., Shanghai, China | 32. | 100.0 | 32. | 100.0 |
44. | RHI Magnesita (Chongqing) Refractory Materials Co., Ltd., Chongqing, China | 43. | 51.0 | 43. | 51.0 |
48. | RHI Magnesita GmbH, Vienna, Austria | 1. | 100.0 | 1. | 100.0 |
49. | RHI Magnesita India Limited, New Delhi, India | 6.,8.,94. | 56.1 | 6.,8.,94. | 56.1 |
50. | RHI Magnesita India Refractories Limited, Rajgangpur, India | 49. | 100.0 | 49. | 100.0 |
51. | RHI Magnesita RE Limited, Guernsey, United Kingdom | 32. | 100.0 | 32. | 100.0 |
52. | RHI Magnesita Sales Germany GmbH, Wiesbaden, Germany | 75. | 100.0 | 75. | 100.0 |
53. | RHI Magnesita Seven Refractories Limited, Dseven, India | 50. | 100.0 | 50. | 100.0 |
54. | RHI Magnesita Switzerland AG, Hünenberg, Switzerland | 32.,47. | 100.0 | 32.,47. | 100.0 |
55. | RHI Magnesita Trading B.V., Rotterdam, Netherlands | 48. | 100.0 | 48. | 100.0 |
56. | RHI Magnesita Turkey Refrakter Ticaret Anonim Sirketi, Eskisehir, Türkiye2) | 15.,32.,90. | 100.0 | 15.,32.,90. | 100.0 |
57. | RHI Magnesita Vietnam Company Limited, Ho Chi Minh City, Vietnam | 63. | 100.0 | 63. | 100.0 |
58. | RHI Magnesita Wetro GmbH, Puschwitz, Germany | 48. | 100.0 | 48. | 100.0 |
59. | RHI Marvo S.R.L., Bucharest, Romania | 32.,90. | 100.0 | 32.,90. | 100.0 |
60. | RHI Refractories (Dalian) Co., Ltd., Dalian, China | 43. | 100.0 | 43. | 100.0 |
61. | RHI Refractories Africa (PTY) LTD, Sandton, South Africa | 32. | 100.0 | 32. | 100.0 |
62. | RHI Refractories Andino, C.A., Puerto Ordaz, Venezuela | 94. | 100.0 | 94. | 100.0 |
63. | RHI Refractories Asia Pacific Pte. Ltd, Singapore, Singapore | 48. | 100.0 | 48. | 100.0 |
64. | RHI Refractories España, S.L., Lugones, Spain | 7.,47. | 100.0 | 7.,47. | 100.0 |
65. | RHI Refractories France SA, Valenciennes, France | 47.,52.,81. | 100.0 | 47.,52.,81. | 100.0 |
66. | RHI Refractories Ibérica, S.L., Oviedo, Spain | 81. | 100.0 | 81. | 100.0 |
67. | RHI Refractories Liaoning Co., Ltd., Bayuquan, China1) | 43. | 100.0 | 43. | 100.0 |
68. | RHI Refractories Nord AB, Stockholm, Sweden | 81. | 100.0 | 81. | 100.0 |
69. | RHI Refractories Raw Material GmbH, Vienna, Austria | 1.,32.,48. | 100.0 | 1.,32.,48. | 100.0 |
70. | RHI Refractories Site Services GmbH, Wiesbaden, Germany | 47. | 100.0 | 47. | 100.0 |
71. | RHI Refractories UK Limited, Bonnybridge, United Kingdom | 47. | 100.0 | 47. | 100.0 |
72. | RHI Refratãrios Brasil Ltda., Contagem, Brazil | 6.,28. | 100.0 | 6.,28. | 100.0 |
73. | RHI Trading (Dalian) Co., Ltd, Dalian, China | 43. | 100.0 | 43. | 100.0 |
74. | RHI Ukraina LLC, Dnepropetrovsk, Ukraine | 32.,90. | 100.0 | 32.,90. | 100.0 |
75. | RHI Urmitz AG & Co. KG, Mülheim-Kärlich, Germany | 47.,70. | 100.0 | 47.,70. | 100.0 |
76. | RHI US Ltd., Delaware, USA | 8. | 100.0 | 8. | 100.0 |
77. | RHI Wostok Limited Liability Company, Moscow, Russia | 32.,48. | 100.0 | 32.,48. | 100.0 |
78. | RHI Wostok Service Limited Liability Company, Moscow, Russia | 32.,48. | 100.0 | 32.,48. | 100.0 |
79. | RHIM Mireco Mitterdorf GmbH, St.Barbara im Mürztal, Austria | 11. | 100.0 | 11. | 100.0 |
80. | RHI-Refmex, S.A. de C.V., Ramos Arizpe, Mexico | 55.,64.,94. | 100.0 | 64.,94. | 100.0 |
81. | Sapref AG für feuerfestes Material, Basel, Switzerland | 94. | 100.0 | 94. | 100.0 |
82. | Seven Refractories (UK) Ltd, Rotherham, United Kingdom | 83. | 100.0 | 83. | 76.0 |
83. | Seven Refractories d.o.o, Divača, Slovenia | 48. | 100.0 | 48. | 100.0 |
84. | Seven Refractories Deutschland GmbH, Düsseldorf, Germany | 48. | 100.0 | 48. | 100.0 |
85. | Seven Refractories Holding, Inc., Huron, USA | 83. | 100.0 | 83. | 100.0 |
Notes to the CompanY Financial Statements 2024 | ||||
31.12.2024 | 31.12.2023 | ||||
Ser. no. | Name and country of incorporation of the company | Share- holder | Share in % | Share- holder | Share in % |
86. | Seven Refractories Limited, Nicosia, Cyprus | 83. | 100.0 | 83. | 51.0 |
87. | Seven Refractories S.r.l., Castellazzo Bormida, Italy | 83. | 100.0 | 83. | 100.0 |
88. | Sipra S.p.A., Bergamo, Italy | 83. | 52.0 | 83. | 52.0 |
89. | Sörmaş Söğüt Refrakter Malzemeleri Anonim Şirketi, Söğüt / Bilecik, Türkiye | 32. | 91.3 | 32. | 91.0 |
90. | Veitscher Vertriebsgesellschaft m.b.H., Vienna, Austria | 48. | 100.0 | 48. | 100.0 |
91. | Veitsch-Radex GmbH, Vienna, Austria | 48. | 100.0 | 48. | 100.0 |
92. | Veitsch-Radex GmbH & Co OG, Vienna, Austria | 48. | 100.0 | 48. | 100.0 |
93. | Veitsch-Radex Vertriebsgesellschaft m.b.H., Vienna, Austria | 48. | 100.0 | 48. | 100.0 |
94. | VRD Americas B.V., Arnhem, Netherlands | 32.,48. | 100.0 | 32.,48. | 100.0 |
95. | Zimmermann & Jansen GmbH, Wiesbaden, Germany | 47. | 100.0 | 47. | 100.0 |
96. | Dr.-Ing. Petri & Co. Unterstützungs-Gesellschaft m.b.H., Wiesbaden, Germany | 47. | 100.0 | 47. | 100.0 |
97. | Horn & Co Polska sp. z o.o., Chorzów, Poland | 11. | 100.0 | 11. | 100.0 |
98. | Magnesita Refractories Private Limited, Mumbai, India 3) | 33. | 100.0 | n/a | 100.0 |
99. | Minerals and Metals Recovering - Mireco Aktiebolag, Fagersta, Sweden | 11. | 100.0 | 11. | 100.0 |
100. | Mireco SARL, Entzheim, France | 11. | 100.0 | 11. | 100.0 |
101. | Mireco SH.P.K, Lebushe, Kosovo | 11. | 100.0 | 11. | 100.0 |
102. | Rudgruvans Industrier Aktiebolag, Fagersta, Sweden | 11. | 100.0 | 11. | 100.0 |
Equity-accounted joint ventures and associated companies | |||||
103. | Chongqing Boliang Refractory Materials Co., Ltd., Chongqing, China | 43. | 51.0 | 43. | 51.0 |
104. | Magnesita-Envoy Asia Ltd., Kaohsiung, Taiwan | 3. | 50.0 | 3. | 50.0 |
105. | P-D Kremen d.o.o., Šentjernej, Slovenia | 30. | 50.0 | 30. | 50.0 |
Notes to the Company Financial Statements 2024Continued |
in € million | 31.12.2024 | 31.12.2023 |
Trade payables | 0 | 1 |
Payables to group companies | 3 | 5 |
Accrued liabilities | 5 | 7 |
Total current liabilities | 8 | 13 |
Notes to the CompanY Financial Statements 2024 | ||||
in € million | 2024 | 2023 |
External services/consulting expenses | (2) | (6) |
Personnel expenses | (21) | (21) |
Other expenses | (2) | (3) |
Total general and administrative expenses | (25) | (30) |
in € million | 2024 | 2023 |
Wages and salaries | (18) | (18) |
Social security charges | (1) | (1) |
Pension contributions | (1) | (1) |
Other employee costs | (1) | (1) |
Total wages and salaries | (21) | (21) |
in € million | 2024 |
Profit attributable to shareholders | 142 |
In accordance with Article 27 clause 1 to be transferred to reserves | 0 |
At the disposal of the General Meeting of Shareholders | 142 |
Notes to the Company Financial Statements 2024Continued |
Notes to the CompanY Financial Statements 2024 | ||||
Executive Directors | |
Stefan Borgas | Ian Botha |
Non-Executive Directors |
Herbert Cordt | John Ramsay |
Janet Ashdown | David Schlaff |
Stanislaus Prinz zu Sayn-Wittgenstein Berleburg | Janice “Jann” Brown |
Karl Sevelda | Marie-Hélène Ametsreiter |
Wolfgang Ruttenstorfer | A. Katarina Lindström |
Employee Representative Directors | |
Karin Garcia | Martin Kowatsch |
Michael Schwarz | |
OTHER INFORMATION Continued |
OTHER iNFORMATION | ||||
OTHER INFORMATION Continued |
Materiality • Overall materiality: €15.6 million. |
Audit scope • We conducted audit work in 11 locations. • Site visits were conducted in Austria, Brazil, India and the United States of America. • Audit coverage: 78% of consolidated revenue, 78% of consolidated total assets and 76% of consolidated profit before tax. |
Key audit matters • Valuation of goodwill; and • Recognition and valuation of uncertain tax positions. |
OTHER iNFORMATION | ||||
Overall group materiality | €15.6 million (2023: €14 million). |
Basis for determining materiality | We used our professional judgement to determine overall materiality. As a basis for our judgement, we used 5% of profit before tax adjusted for certain non-operating items. |
Rationale for benchmark applied | We used profit before tax adjusted for certain non-operating items (e.g. restructuring costs, digital transformation implementation costs and impairments of non-current assets recorded as Other income or Other expense) as the primary benchmark, a generally accepted auditing practice, based on our analysis of the common information needs of the users of the financial statements. On this basis, we believe that profit before tax adjusted for non-operating items is the most relevant metric for assessing the financial performance of the Group. |
Component materiality | Based on our judgement, we allocate materiality to each component in our audit scope that is less than our overall group materiality. The range of materiality allocated across components was between €1.5 million and €12.5 million. |
Revenue | 78% |
Total assets | 78% |
Profit before tax | 76% |
OTHER INFORMATION Continued |
OTHER iNFORMATION | ||||
Identified fraud risks | Our audit work and observations | |
Risk of management override of controls It is generally presumed that management is in a unique position to perpetrate fraud because of the opportunity to manipulate accounting records and prepare fraudulent financial statements by overriding manual controls, such as those related to journal entries, related party transactions, significant accounting estimates, etc. Adjusted EBITDA and adjusted EBITA are key financial measures that the board of directors and the executive management team use to assess the performance of the Group. Adjusted EBITA and adjusted operating cash flow are furthermore key financial incentives for the executive directors. A strong focus on meeting these financial targets could potentially provide management an incentive for overriding controls. | Where relevant to our audit, we evaluated the design and effectiveness of controls in the processes of generating and processing journal entries. We assessed whether deficiencies in controls may create additional opportunities for fraud and incorporated respective corroborative procedures in our audit approach. We considered the outcome of our audit procedures over the estimates and significant accounting areas and assessed whether control deficiencies and misstatements identified could be indicative of fraud. Where necessary, we planned and performed additional audit procedures to ensure that fraud risks are sufficiently addressed in our audit. We paid specific attention to the access safeguards in the IT systems and the set-up of the segregation of duties in systems and processes. Together with management we assessed the business rationale for conflicting user rights when these were identified within the IT environment. We performed data analysis focused on journal entries using defined fraud risk-criteria identified as part of our fraud risk assessment. Where we identified instances of unexpected journal entries, we performed additional audit procedures. In addition we performed substantive testing procedures over the consolidation entries. We evaluated key accounting estimates and judgements used in accounting areas where management judgement is applied (e.g. recognition and valuation of provisions, eligibility of capitalisation of expenses) for biases, including retrospective reviews of prior year’s estimates where possible. In this context we also paid specific attention to the support for the change in method for determining inventory provisions as detailed in Note 3 of the consolidated financial statements. We evaluated the business rationale of the significant transactions concluded in 2024. We incorporated an element of unpredictability in the nature, timing, and extent of audit procedures. Our audit procedures did not identify indications of fraud or suspicions of fraud with respect to management override of controls. | |
Risk of fraud in revenue recognition As part of our risk assessment and based on a presumption that there are risks of fraud in revenue recognition, we considered the risk of fraud in revenue recognition. This relates to the presumed management incentive that exists to overstate revenue in order to meet financial targets, guidance provided to the market or shareholder expectations | We discussed and inquired with the board of directors, the Audit & Compliance Committee and the executive management team about their views on overall fraud risks within the Group, their perspectives on the Group’s mitigating controls addressing the risk of fraud in revenue and whether they have any knowledge of (suspected) fraud. Where relevant to our audit, we have evaluated the design of the internal control measures, including automated revenue related controls in the relevant IT systems, that are intended to mitigate the risk of fraud in revenue recognition and assessed the operating effectiveness of those measures. Through data analysis using defined risk-criteria, we tested unexpected journal entries across all relevant revenue streams. We tested, on a sample basis, the performance and transaction prices of revenue transactions based on sales agreements, delivery documents, sales invoices and/or cash receipts. We tested the receivable balances at year end via external confirmations or alternative procedures if these were not received. We also paid specific attention to the appropriateness of the change in application for determining the moment of revenue recognition for products sold under CIF/CFR incoterms as detailed in Note 3 of the consolidated financial statements. We did not identify specific indications of fraud or suspicion of fraud in respect of revenue recognition |
OTHER INFORMATION Continued |
OTHER iNFORMATION | ||||
Key audit matter | Our audit work and observations | |
Valuation of goodwill Refer to notes 3, 4 and 17 of the consolidated financial statements The Group recognised goodwill of €342 million, which is allocated to various cash-generating units (‘CGUs’). At least on an annual basis, these goodwill balances per CGU are tested for possible impairment. The Group prepares the goodwill impairment test using cashflow projections including next year’s budget and the long-term planning covering four subsequent years. The key assumptions used in the projections are: projected sales (growth), EBIT margin, discount rate and terminal value growth rate. As disclosed in note 4 of the consolidated financial statements, the Group has considered the long-term impact of climate change, in particular by considering a long-term growth rate in the estimation of the terminal value in line with the change in steel and cement demand on the longer term based on the specific characteristics of the businesses involved. Management also considered and modelled the potential impact of the European Carbon Border Adjustment Mechanism (CBAM) regulation on its assets located within Europe. The goodwill impairment test did not result in an impairment. We identified the valuation of goodwill as a key audit matter due to significant estimates and assumptions used with respect to, among others, discount rates, profitability forecasts and growth rates. | In the context of the annual goodwill impairment test, we have performed various procedures which varied in depth per CGU based on our risk assessment with respect to the related goodwill balances as compared to our materiality used. Our audit procedures included, among others: ● Assessing the appropriateness of management’s identification of the Group’s CGUs based on management’s monitoring of the business and decision making processes as well as the allocation of goodwill and carrying values to these CGUs. ● Evaluating and challenging the composition of management’s future cash flow forecasts and the process by which they were drawn up as well as the key assumptions underlying the valuation model used by the Group, which includes, among others, the projected sales growth rates, the projected EBIT margin, the discount rate and terminal value growth rate. We have compared and challenged management’s assumptions against available external benchmarks, available competitor information and our own accumulated industry knowledge. ● Performing a retrospective review of the prior year estimates by comparing the current year actual results to those projected in the prior year. ● Assessing the appropriateness of the valuation methodology applied against generally accepted valuation techniques as well as reperforming the calculations made to determine the respective carrying and recoverable values resulting from the model. ● Assessing the adequacy of the Company’s disclosures regarding assumptions and sensitivities as included in Note 17 to the consolidated financial statements. Based on the audit procedures performed, we found the assumptions to be reasonable and supported by available evidence. | |
Recognition and valuation of uncertain tax positions Refer to notes 3 and 38 of the consolidated financial statements As described in Note 38 of the consolidated financial statements, the Group is party to several tax proceedings in Brazil which involve estimated contingent liabilities amounting to €117 million. Given that the tax legislation in Brazil is complex and unpredictable, and is also going through a major reform, this could give rise to significant uncertainties and the Group’s estimate of tax liabilities may differ from interpretations by the relevant tax authorities as to how regulations should be applied to actual transactions. Judgement is therefore required by management to determine whether it is probable that an uncertain tax position should be recognised. Due to the inherent level of uncertainty, the significant judgement involved as well as the potential limitations in the recoverability of uncertain tax positions, we considered the recognition and valuation of uncertain tax positions to be a key audit matter for our audit. | With regard to the recognition and valuation of uncertain tax positions we have requested and obtained management’s assessment of such uncertain tax positions taken, reviewed correspondence with the tax authorities, reviewed independent legal and tax opinions as well as the latest available tax filings. We corroborated the assessment made with Group management and the local auditors as well as internal tax specialists. We also analysed the recent resolutions of tax disputes in Brazil. Based on the audit procedures performed, we found the Group’s estimates and judgement used in the recognition and valuation of uncertain tax positions to be appropriately supported. We furthermore assessed the disclosures made in the consolidated financial statements to be adequate and appropriate. |
OTHER INFORMATION Continued |
OTHER iNFORMATION | ||||